Bio-Path Stock Price (NASDAQ:BPTH)

Add to My Stocks
$0.69 $0.02 (2.82%) BPTH stock closing price Apr 25, 2017 (Closing)
Prev Close* : $0.71
Market Cap:
$67.9M
Day Low: $0.67
52 Week Low: $0.54
Open: $0.72
Volume: 68029
Day High: $0.72
52 Week High: $2.83
Dividend:
N/A

Latest Stock Market News

Latest Articles

Bio-Path News - From Partners

BPTH Stockcharts

View BPTH PE ratio, PS ratio stocks charts and compare with peers.
BPTH Chart
Note: Compare Bio-Path stock price history with the index and industry peers.

BPTH Industry Peers

Company Price Change (%)
Intellipharmaceutics (IPCI)1.890 (0%)
Natural Alternatives International (NAII)9.550.2 (2.14%)
Ariad Pharma (ARIA)23.990 (0%)
Macrogenics (MGNX)21.50.55 (2.63%)
Seattle Genetics (SGEN)66.81.27 (1.94%)
Stemline Therapeutics (STML)9.10.35 (4%)
Pdl Biopharma (PDLI)2.230.07 (3.24%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
CTI BioPharma (CTIC)4.260.28 (7.04%)
USANA Health Sciences (USNA)58.553.3 (5.97%)
Ignyta (RXDX)8.950.5 (5.92%)
ImmunoGen (IMGN)4.330.22 (5.35%)
Valeant Pharmaceuticals Intl Inc (VRX)9.020.42 (4.88%)
Ionis Pharma (IONS)47.882.14 (4.68%)
Spectrum Pharma (SPPI)7.630.32 (4.38%)
Top gainers from Medical-Drugs industry
* As of Apr 26, 2017
CompanyPriceChange (%)
Karyopharm Therapeutics (KPTI)10.410.9 (7.96%)
Durect (DRRX)0.8430.05 (5.61%)
Genocea Biosciences (GNCA)6.860.24 (3.38%)
Nature's Sunshine Products (NATR)9.90.3 (2.94%)
Egalet (EGLT)4.230.11 (2.53%)
AcelRx Pharma (ACRX)2.550.05 (1.92%)
Esperion Therapeutics (ESPR)37.050.49 (1.31%)
Top losers from Medical-Drugs industry
* As of Apr 26, 2017

Bio-Path Financial Statements

income statement20162015201420132012
Net Sales Or Revenues0.01M----
Net Income-6.75M-5.46M-4.51M-3.26M-2.58M
Total Operating Expense8.48M5.48M4.53M3.26M2.57M
view Bio-Path Holdings Inc income statement
balance sheet20162015201420132012
Total Assets12.19M10.75M15.47M5.07M2.34M
Total Liabilities3.95M0.93M0.56M0.29M0.32M
Shareholders Equity8.24M9.81M14.91M4.78M2.01M
view Bio-Path Holdings Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-0.67M-0.1M0.12M0.08M-0.02M
Net Cash From (Used By) Operating Activities-8.14M-5M-3.81M-2.31M-1.99M
Increase (Decrease) In Prop Plant And Equipment-0.33M--0.12M--
view Bio-Path Holdings Inc cashflow statement

Bio-Path Stock Message Board

An investor needs to spend 0.69 to buy BPTH stock, as the closing Bio-Path stock price is 0.69. Stock price or share price can be used to find the total market value of a company. Bio-Path market cap stands at 67.9M as of 25 Apr, 2017. A value investor must look at the fundamentals of a stock, and perform Bio-Path valuation, even though in the short-term sentiment and current breaking news might affect Bio-Path stock price.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Bio-Path is worth a lot, it will most likely be reflected in an inflated Bio-Path stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 68029 shares were traded with a closing stock price of 0.69 as of 25 Apr, 2017, as can be seen from Bio-Path stock quote. One can view Bio-Path stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Bio-Path stock price history, gives the entire historical data for BPTH stock.